P. Werner

646 total citations
17 papers, 480 citations indexed

About

P. Werner is a scholar working on Psychiatry and Mental health, Genetics and Molecular Biology. According to data from OpenAlex, P. Werner has authored 17 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 3 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in P. Werner's work include Schizophrenia research and treatment (5 papers), HIV Research and Treatment (2 papers) and Attention Deficit Hyperactivity Disorder (2 papers). P. Werner is often cited by papers focused on Schizophrenia research and treatment (5 papers), HIV Research and Treatment (2 papers) and Attention Deficit Hyperactivity Disorder (2 papers). P. Werner collaborates with scholars based in United States, Switzerland and Canada. P. Werner's co-authors include Kuan Zhang, Carol N. Boozer, Ming Sun, F. Xavier Pi‐Sunyer, Carol Moskowitz, James Godbold, Karen Marder, David M. Simpson, Alessandro Di Rocco and Jeanine Albu and has published in prestigious journals such as American Journal of Clinical Nutrition, Neurology and Clinical Orthopaedics and Related Research.

In The Last Decade

P. Werner

17 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. Werner United States	9	176	102	63	61	59	17	480
Graziella Milan Italy	18	146 0.8×	78 0.8×	28 0.4×	242 4.0×	28 0.5×	30	859
Pablo Lecumberri Spain	16	233 1.3×	33 0.3×	177 2.8×	154 2.5×	61 1.0×	34	818
B.W. Dijkstra Netherlands	14	130 0.7×	49 0.5×	75 1.2×	80 1.3×	5 0.1×	22	602
Dennis Seow Singapore	11	89 0.5×	48 0.5×	19 0.3×	84 1.4×	22 0.4×	26	698
Sean A. Horan Australia	18	171 1.0×	54 0.5×	379 6.0×	131 2.1×	16 0.3×	43	1.0k
Delaram Safarpour United States	11	77 0.4×	33 0.3×	66 1.0×	71 1.2×	51 0.9×	33	447
Daryl Wile Canada	9	117 0.7×	22 0.2×	51 0.8×	36 0.6×	73 1.2×	19	526
Ram Kinker Mishra United States	14	63 0.4×	29 0.3×	53 0.8×	104 1.7×	42 0.7×	36	430
Raphael Knaier Switzerland	16	244 1.4×	65 0.6×	42 0.7×	38 0.6×	4 0.1×	46	692
Bei Zhang China	16	48 0.3×	77 0.8×	17 0.3×	35 0.6×	22 0.4×	62	568

Countries citing papers authored by P. Werner

Since Specialization

Citations

This map shows the geographic impact of P. Werner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Werner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Werner more than expected).

Fields of papers citing papers by P. Werner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Werner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Werner. The network helps show where P. Werner may publish in the future.

Co-authorship network of co-authors of P. Werner

This figure shows the co-authorship network connecting the top 25 collaborators of P. Werner. A scholar is included among the top collaborators of P. Werner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Werner. P. Werner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Lafayette, Richard, Bruce McCall, Nicole Li, et al.. (2014). Incidence and Relevance of Proteinuria in Bevacizumab-Treated Patients: Pooled Analysis from Randomized Controlled Trials. American Journal of Nephrology. 40(1). 75–83. 35 indexed citations

Correll, Christoph U., et al.. (2013). P.3.d.045 Early improvement predicts endpoint response to lurasidone in schizophrenia: pooled analysis of five double-blind trials. European Neuropsychopharmacology. 23. S485–S485. 1 indexed citations

Werner, P., Takeo Ishiyama, Antony Loebel, et al.. (2013). 1053 – In Vitro Receptor-binding Profile Of Lurasidone And Other Commonly-used Antipsychotics. European Psychiatry. 28(S1). 1 indexed citations

McEvoy, J., Leslie Citrome, Jay Hsu, et al.. (2013). 1046 – Switching To Lurasidone In Patients With Schizophrenia: Tolerability And Effectiveness At 6 Weeks And 6 Months. European Psychiatry. 28(S1). 2 indexed citations

McEvoy, Joseph P., Leslie Citrome, David Hernández, et al.. (2013). P.3.d.047 Switching to lurasidone in patients with schizophrenia: tolerability and effectiveness at 6 weeks and 6 months. European Neuropsychopharmacology. 23. S486–S486. 1 indexed citations

Lieberman, Jeffrey A., et al.. (2013). 1051 – Lurasidone In The Treatment Of Early-stage Schizophrenia: a Post-hoc Analysis Of Three Pooled Acute Treatment Studies. European Psychiatry. 28(S1). 1 indexed citations

Migliore, Raffaele, et al.. (2011). The efficacy and safety of the novel antipsychotic cariprazine in acute exacerbation of schizophrenia. European Psychiatry. 26(S2). 1354–1354. 11 indexed citations

Lecrubier, Y., et al.. (2010). P.2.c.038 Efficacy of levomilnacipran in improving symptoms and functional impairment associated with major depressive disorder. European Neuropsychopharmacology. 20. S390–S390. 1 indexed citations

Migliore, Raffaele, et al.. (2010). P.3.c.062 The efficacy and safety of the novel antipsychotic cariprazine in acute exacerbation of schizophrenia. European Neuropsychopharmacology. 20. S493–S494. 8 indexed citations

10.

Zhang, Kuan, et al.. (2005). Energy balance in early-stage Huntington disease. American Journal of Clinical Nutrition. 81(6). 1335–1341. 59 indexed citations

11.

Rocco, Alessandro Di, P. Werner, T. Bottiglieri, et al.. (2004). Treatment of AIDS-associated myelopathy with l -methionine. Neurology. 63(7). 1270–1275. 22 indexed citations

12.

Zhang, Kuan, P. Werner, Ming Sun, F. Xavier Pi‐Sunyer, & Carol N. Boozer. (2003). Measurement of Human Daily Physical Activity. Obesity Research. 11(1). 33–40. 235 indexed citations

13.

Sun, Ming, et al.. (2002). Sleeping metabolic rate in relation to body mass index and body composition. International Journal of Obesity. 26(3). 376–383. 48 indexed citations

14.

Rocco, Alessandro Di, Teodoro Bottiglieri, P. Werner, et al.. (2002). Abnormal cobalamin-dependent transmethylation in AIDS-associated myelopathy. Neurology. 58(5). 730–735. 40 indexed citations

15.

Rocco, Alessandro Di, P. Werner, Michele Tagliati, et al.. (2000). AIDS myelopathy is not associated with elevated HIV viral load in cerebrospinal fluid. Neurology. 55(3). 440–442. 12 indexed citations

16.

Rosberger, Daniel F., P. Werner, R M Steinman, et al.. (1989). Group specific component (Gc) and HIV diseases.. PubMed. 6(4). 269–74. 2 indexed citations

17.

Werner, P., et al.. (1981). Nursing Care of an Osteogenesis Imperfecta Infant and Child. Clinical Orthopaedics and Related Research. 159(159). 108–110. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact